US 8895539
Pregnancy hormone combination for treatment of autoimmune diseases
granted A61KA61K31/56A61K31/565
Quick answer
US patent 8895539 (Pregnancy hormone combination for treatment of autoimmune diseases) held by The Regents of the University of California expires Mon Nov 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Nov 25 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 33
- CPC classes
- A61K, A61K31/56, A61K31/565, A61K31/57, A61K31/785